enprofylline has been researched along with Dermatitis, Contact in 2 studies
enprofylline : Xanthine bearing a propyl substituent at position 3. A bronchodilator, it is used for the symptomatic treatment of asthma and chronic obstructive pulmonary disease, and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy.
Dermatitis, Contact: A type of acute or chronic skin reaction in which sensitivity is manifested by reactivity to materials or substances coming in contact with the skin. It may involve allergic or non-allergic mechanisms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Solinski, HJ | 1 |
| Dranchak, P | 1 |
| Oliphant, E | 1 |
| Gu, X | 1 |
| Earnest, TW | 1 |
| Braisted, J | 1 |
| Inglese, J | 1 |
| Hoon, MA | 1 |
| Zunich, KM | 1 |
| Nelson, HS | 1 |
| Patel, A | 1 |
| Bodman, S | 1 |
| Gilner, D | 1 |
| Winder, J | 1 |
1 trial available for enprofylline and Dermatitis, Contact
| Article | Year |
|---|---|
The effect of theophylline and enprofylline on the late cutaneous response to antigen and compound 48/80.
Topics: Adult; Antigens; Dermatitis, Contact; Double-Blind Method; Humans; Hypersensitivity, Immediate; p-Me | 1989 |
1 other study available for enprofylline and Dermatitis, Contact
| Article | Year |
|---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, S | 2019 |